Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001185185-17-001858
Filing Date
2017-08-25
Accepted
2017-08-25 16:03:18
Documents
1
Period of Report
2017-08-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4-borman082317.html 4  
1 OWNERSHIP DOCUMENT form4-borman082317.xml 4 4462
  Complete submission text file 0001185185-17-001858.txt   5941
Mailing Address 13794 NW 4TH STREET SUITE 212 SUNRISE FL 33325
Business Address 13794 NW 4TH STREET SUITE 212 SUNRISE FL 33325 954-835-1500
U.S. Stem Cell, Inc. (Issuer) CIK: 0001388319 (see all company filings)

EIN.: 650945967 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 5240 WASHBURN AVENUE SOUTH MINNEAPOLIS MN 55410
Business Address
Borman Mark P (Reporting) CIK: 0001464280 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33718 | Film No.: 171052015